Reduced complexity nucleic acid targets and methods of using same
AssigneeSidney Kimmel Cancer Center
InventorsMichael McClelland, John Welsh, Thomas Trenkle
Life of this patent
Estimating the term…
Loading patent…
AssigneeSidney Kimmel Cancer Center
InventorsMichael McClelland, John Welsh, Thomas Trenkle
Estimating the term…
The invention provides a method of measuring the level of two or more nucleic acid molecules in a target by contacting a probe with a target comprising two or more nucleic acid molecules, wherein the nucleic acid molecules are arbitrarily sampled and wherein the arbitrarily sampled nucleic acid molecules comprise a subset of the nucleic acid molecules in a population of nucleic acid molecules; and detecting the amount of specific binding of the target to the probe. The invention also provides a method of measuring the level of two or more nucleic acid molecules in a target by contacting a probe with a target comprising two or more nucleic acid molecules, wherein the nucleic acid molecules are statistically sampled and wherein the statistically sampled nucleic acid molecules comprise a subset of the nucleic acid molecules in a population of nucleic acid molecules; and detecting the amount of specific binding of the target to the probe.
A method of measuring the level of two or more nucleic acid molecules in a target, comprising:
A method of measuring the level of two or more nucleic acid molecules in a target, comprising:
A profile comprising five or more stimulus-regulated nucleic acid molecules.
A target comprising a portion of each of the nucleotide sequences referenced as SEQ ID NOS:1-45.
Dependencies are inferred from the claim text.